CommentStem-cell therapy after acute myocardial infarction: the focus should be on those at risk
References (8)
- et al.
Autologous bone marrow-derived stem cell transfer in patients with ST-segment elevation myocardial infarction: a double-blind, randomised, controlled study
Lancet
(2006) - et al.
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
Lancet
(2004) - et al.
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial
J Am Coll Cardiol
(2004) - et al.
Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy
Lancet
(2003)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2006 Elsevier Ltd. All rights reserved.